T. Rowe Price Investment Management
ELAN icon

T. Rowe Price Investment Management’s Elanco Animal Health ELAN Stock Holding History

T. Rowe Price Investment Management’s Portfolio ELAN Stock Details ELAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$829M Sell
34,635,086
-592,332
-2% -$14.5M 0.57% 39
2025
Q4 		$797M Buy
35,227,418
+3,717,404
+12% +$80.9M 0.5% 50
2025
Q3 		$635M Buy
31,510,014
+11,955,072
+61% +$200M 0.39% 65
2025
Q2 		$279M Buy
19,554,942
+3,571,551
+22% +$41.7M 0.18% 139
2025
Q1 		$168M Buy
15,983,391
+292,655
+2% +$3.31M 0.11% 194
2024
Q4 		$190M Sell
15,690,736
-5,352,070
-25% -$70M 0.12% 186
2024
Q3 		$309M Buy
21,042,806
+11,272,346
+115% +$157M 0.19% 130
2024
Q2 		$141M Buy
9,770,460
+421,847
+5% +$6.74M 0.09% 226
2024
Q1 		$152M Buy
9,348,613
+3,516,125
+60% +$55M 0.09% 225
2023
Q4 		$86.9M Buy
5,832,488
+3,522,982
+153% +$39.9M 0.06% 295
2023
Q3 		$26M Buy
+2,309,506
New +$26.8M 0.02% 453

Other funds holding ELAN

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management's ELAN Position: Q1 2026 in Review

T. Rowe Price Investment Management reduced its Elanco Animal Health (ELAN) stake by 1.7% in Q1 2026, selling an estimated $14.5M and leaving 34,635,086 shares worth $829M. The position accounts for 0.57% of the portfolio, ranked #39.

T. Rowe Price Investment Management first reported a position in ELAN in Q3 2023 and has held it in 11 quarters since. 516 funds tracked by Wall St. Rank hold ELAN as of Q1 2026.

  • T. Rowe Price Investment Management held 34,635,086 shares of Elanco Animal Health worth $829M as of Q1 2026.
  • T. Rowe Price Investment Management sold 592,332 Elanco Animal Health shares in Q1 2026, an estimated $14.5M.
  • Elanco Animal Health made up 0.57% of T. Rowe Price Investment Management's portfolio in Q1 2026, its #39 holding.
  • T. Rowe Price Investment Management first reported a position in Elanco Animal Health in Q3 2023 and has held it in 11 quarters since.
  • 516 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2026.

Based on T. Rowe Price Investment Management's 13F filing for Q1 2026, filed 15 May 2026.